Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer [1]
The wroth of neoadjuvant treatment in conjunction with resection as multimodality therapy (MMT) for stage IIB non-small cell lung cancer is still controversial.
Source name:
The Annals of Thoracic Surgery
Resource link: